Investors



Cortendo AB 2016 Annual General Meeting / Årsstämma

View Investor Presentation


Corporate Profile

Strongbridge Biopharma is a global rare disease biopharmaceutical company focused on the development and commercialization of novel therapeutic options. Founded in 1996, the Company is domiciled in Ireland and based in the United States. The Company is publicly traded on the NASDAQ Global Market under the ticker symbol SBBP.

Read More


 |NASDAQ GS SBBP (Common Stock)
$4.81 - 0.01
Stock chart for: SBBP.O.  Currently trading at $4.81 with a 52 week high of $14.30 and a 52 week low of $3.30.
Data provided by Nasdaq. Minimum 15 minutes delayed.



Press Releases



Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2n

July 6, 2016

DUBLIN, Ireland and TREVOSE, Pa., July 06, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutica....

Read More

Strongbridge Biopharma plc to Participate in the JMP Securities Life Scienc

June 14, 2016

DUBLIN, Ireland and TREVOSE, Pa., June 14, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutica....

Read More

View More

Upcoming Events



View More